Cargando…
Inhibition of renal fibrosis with a human CXCL9‐derived glycosaminoglycan‐binding peptide
OBJECTIVES: Renal fibrosis accompanies all chronic kidney disorders, ultimately leading to end‐stage kidney disease and the need for dialysis or even renal replacement. As such, renal fibrosis poses a major threat to global health and the search for effective therapeutic strategies to prevent or tre...
Autores principales: | Poosti, Fariba, Soebadi, Mohammad Ayodhia, Crijns, Helena, De Zutter, Alexandra, Metzemaekers, Mieke, Berghmans, Nele, Vanheule, Vincent, Albersen, Maarten, Opdenakker, Ghislain, Van Damme, Jo, Sprangers, Ben, Proost, Paul, Struyf, Sofie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810938/ https://www.ncbi.nlm.nih.gov/pubmed/35140938 http://dx.doi.org/10.1002/cti2.1370 |
Ejemplares similares
-
Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47–70) and CXCL4L1(47–70) in an EGF-dependent breast cancer model
por: Van Raemdonck, Katrien, et al.
Publicado: (2014) -
Matrix Metalloproteinase-9-Generated COOH-, but Not NH(2)-Terminal Fragments of Serum Amyloid A1 Retain Potentiating Activity in Neutrophil Migration to CXCL8, With Loss of Direct Chemotactic and Cytokine-Inducing Capacity
por: Gouwy, Mieke, et al.
Publicado: (2018) -
CXCL9-Derived Peptides Differentially Inhibit Neutrophil Migration In Vivo through Interference with Glycosaminoglycan Interactions
por: Vanheule, Vincent, et al.
Publicado: (2017) -
Targeting Chemokine—Glycosaminoglycan Interactions to Inhibit Inflammation
por: Crijns, Helena, et al.
Publicado: (2020) -
Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands
por: Metzemaekers, Mieke, et al.
Publicado: (2018)